| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $901.3M | $782.1M | $557.7M |
| YoY Revenue Growth % | +15.2% | +40.2% | — |
| Gross Profit | $400.1M | $391.6M | — |
| Gross Margin % | 44.4% | 50.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $109.4M | $151.0M | $95.8M |
| Operating Margin % | 12.1% | 19.3% | 17.2% |
| Net Income (GAAP) | $94.1M | $103.6M | $77.3M |
| EBITDA (Normalized) | $154.5M | $217.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$10.3M | $152.4M | -$75.3M |
| Capital Expenditures (CapEx) | $56.3M | $82.5M | — |
| Free Cash Flow (FCF) | -$66.6M | $70.0M | -$75.3M |
| FCF Margin % | -7.4% | 8.9% | -13.5% |
| Return on Invested Capital (ROIC %) | 9.8% | 19.8% | — |
| Cash & Short-Term Equivalents | $757.4M | $407.4M | — |
| Total Debt (Short + Long Term) | $178.9M | $105.5M | — |
| Total Stockholders' Equity | $1.46B | $904.6M | — |